Evidence and consensus-based recommendations for non-pharmacological treatment of fatigue, hand function loss, Raynaud's phenomenon and digital ulcers in patients with systemic sclerosis.
RP
SSc
digital ulcers
fatigue
hand function loss
Journal
Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501
Informations de publication
Date de publication:
11 04 2022
11 04 2022
Historique:
received:
15
04
2021
revised:
25
06
2021
pubmed:
15
7
2021
medline:
14
4
2022
entrez:
14
7
2021
Statut:
ppublish
Résumé
SSc is a complex CTD affecting mental and physical health. Fatigue, hand function loss, and RP are the most prevalent disease-specific symptoms of systemic sclerosis. This study aimed to develop consensus and evidence-based recommendations for non-pharmacological treatment of these symptoms. A multidisciplinary task force was installed comprising 20 Dutch experts. After agreeing on the method for formulating the recommendations, clinically relevant questions about patient education and treatments were inventoried. During a face-to-face task force meeting, draft recommendations were generated through a systematically structured discussion, following the nominal group technique. To support the recommendations, an extensive literature search was conducted in MEDLINE and six other databases until September 2020, and 20 key systematic reviews, randomized controlled trials, and published recommendations were selected. Moreover, 13 Dutch medical specialists were consulted on non-pharmacological advice regarding RP and digital ulcers. For each recommendation, the level of evidence and the level of agreement was determined. Forty-one evidence and consensus-based recommendations were developed, and 34, concerning treatments and patient education of fatigue, hand function loss, and RP/digital ulcers-related problems, were approved by the task force. These 34 recommendations provide guidance on non-pharmacological treatment of three of the most frequently described symptoms in patients with systemic sclerosis. The proposed recommendations can guide referrals to health professionals, inform the content of non-pharmacological interventions, and can be used in the development of national and international postgraduate educational offerings.
Identifiants
pubmed: 34260723
pii: 6321467
doi: 10.1093/rheumatology/keab537
pmc: PMC8996778
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1476-1486Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology.
Références
Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S153-9
pubmed: 26339894
Arthritis Care Res (Hoboken). 2011 Feb;63(2):277-85
pubmed: 20824802
Am J Occup Ther. 2019 Jul/Aug;73(4):7304205020p1-7304205020p21
pubmed: 31318666
Ann Rheum Dis. 2020 Jan;79(1):53-60
pubmed: 31399400
Rheumatol Int. 2021 Jul;41(7):1299-1310
pubmed: 33355711
Ann Rheum Dis. 1982 Apr;41(2):147-52
pubmed: 7073343
Fam Pract. 1993 Mar;10(1):76-81
pubmed: 8477899
BMC Rheumatol. 2020 Jul 31;4:43
pubmed: 32760879
Semin Arthritis Rheum. 2017 Oct;47(2):204-215
pubmed: 28477898
J Hand Ther. 2019 Apr - Jun;32(2):194-211
pubmed: 30587434
Arthritis Rheum. 2009 Jul 15;61(7):966-73
pubmed: 19565539
J Rheumatol. 2016 Jul;43(7):1363-75
pubmed: 27134259
Arthritis Rheum. 2008 Jul 15;59(7):968-73
pubmed: 18576298
Rheumatology (Oxford). 2009 Feb;48(2):165-9
pubmed: 19106163
Arthritis Res Ther. 2018 Jun 5;20(1):112
pubmed: 29871697
J Scleroderma Relat Disord. 2021 Feb;6(1):96-101
pubmed: 35382248
Ann Rheum Dis. 2004 Sep;63(9):1172-6
pubmed: 15308532
Lancet. 2017 Oct 7;390(10103):1685-1699
pubmed: 28413064
CMAJ. 2010 Dec 14;182(18):E839-42
pubmed: 20603348
Am J Occup Ther. 1994 Jan;48(1):46-54
pubmed: 8116783
Rheumatol Adv Pract. 2018 Aug 22;2(2):rky027
pubmed: 31431973
J Rheumatol. 1998 Jan;25(1):79-83
pubmed: 9458207
Vasa. 2017 Oct;46(6):413-423
pubmed: 28895508
Ann Rheum Dis. 2015 Jan;74(1):8-13
pubmed: 25261577
Am J Occup Ther. 2017 Jan/Feb;71(1):7101180050p1-7101180050p11
pubmed: 28027042
J Hand Ther. 2019 Jul - Sep;32(3):313-321
pubmed: 29198478
BMJ. 2017 Sep 21;358:j4008
pubmed: 28935701
Ther Clin Risk Manag. 2014 Oct 01;10:775-86
pubmed: 25328393
Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):157-161
pubmed: 27087678
Rheumatol Adv Pract. 2019 Dec 09;3(2):rkz044
pubmed: 31858074
Arthritis Care Res (Hoboken). 2016 Jan;68(1):141-8
pubmed: 26238554
Arthritis Care Res (Hoboken). 2015 Oct;67(10):1426-39
pubmed: 25832447
Health Technol Assess. 2019 Oct;23(57):1-130
pubmed: 31601357
Am J Occup Ther. 1987 Feb;41(2):118-21
pubmed: 3565526
Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):159-166
pubmed: 28869417
J Adv Nurs. 2006 Dec;56(6):617-35
pubmed: 17118041
RMD Open. 2016 Mar 15;2(1):e000159
pubmed: 27042333
Int J Rheum Dis. 2019 Dec;22(12):2096-2107
pubmed: 31621157
Clin Rheumatol. 2020 Jun;39(6):1783-1792
pubmed: 32036584
Cochrane Database Syst Rev. 2013 Aug 23;(8):CD008322
pubmed: 23975674
Arch Phys Med Rehabil. 1997 Jul;78(7):767-73
pubmed: 9228882
Psychol Health Med. 2020 Dec;25(10):1179-1191
pubmed: 32129673
Ann Rheum Dis. 2017 Aug;76(8):1327-1339
pubmed: 27941129
Arthritis Care Res. 1991 Mar;4(1):27-31
pubmed: 11188583
J Pediatr Orthop. 2013 Jul-Aug;33(5):471-8
pubmed: 23752142
Ann Rheum Dis. 2015 Sep;74(9):1636-44
pubmed: 26109736
Scand J Rheumatol. 2013;42(6):483-6
pubmed: 23826651
Ann Rheum Dis. 2015 Jun;74(6):954-62
pubmed: 25735643
Rheumatology (Oxford). 2011 Apr;50(4):762-7
pubmed: 21149249
Arthritis Care Res (Hoboken). 2017 Jul;69(7):1050-1059
pubmed: 27696703
Rheumatology (Oxford). 2016 Oct;55(10):1906-10
pubmed: 27284161
Ann Rheum Dis. 2011 May;70(5):722-6
pubmed: 21257615
RMD Open. 2018 Oct 18;4(Suppl 1):e000782
pubmed: 30402270
Arthritis Care Res. 1996 Feb;9(1):51-9
pubmed: 8945113